Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Orexigen Therapeutics Reduces Q4 Loss by 34%
Motley Fool
Thursday, March 13, 2014 - 9:44am
tags:
earnings, Orexigen
Top 4 Medical Device Stocks For 2014
Seeking Alpha
Thursday, March 13, 2014 - 8:56am
tags:
devices, Medtronic, General Electric, Siemens, Sanomedics
FDA considering new requirements for off-label use data
Mass Device
Thursday, March 13, 2014 - 8:52am
tags:
FDA, off-label
Circassia Raises $333.5 Million in IPO for Allergy Shot
Bloomberg
Thursday, March 13, 2014 - 8:47am
tags:
Circassia, allergy shots, IPOs, Cat-SPIRE, cat allergy
Achaogen grabs $72M from IPO
Fierce Biotech
Thursday, March 13, 2014 - 8:35am
tags:
antibiotics, IPOs, Achaogen
Tesaro pays $17M to team with AnaptysBio on cancer immunotherapies
Fierce Biotech
Thursday, March 13, 2014 - 8:34am
tags:
Tesaro, AnaptysBio, cancer immunotherapy
3 Biotech Stocks Spiking on Big Volume
TheStreet.com
Thursday, March 13, 2014 - 8:29am
tags:
WuXi PharmaTech, NewLink Genetics, Five Prime
Dr. Reddy's recalls some lots of heartburn drug in U.S
Yahoo/Reuters
Thursday, March 13, 2014 - 8:28am
tags:
recalls, Dr Reddy's, Lansoprazole
FDA bans imports from Sun Pharma plant in India crackdown
Yahoo/Reuters
Thursday, March 13, 2014 - 8:26am
tags:
Sun Pharma, India, FDA
Grateful Actavis board adds $4M to CEO's deal-related bonus tally. Total: $49M
Fierce Pharma
Wednesday, March 12, 2014 - 7:07pm
tags:
executive pay, Actavis, Warner Chilcott, M&A
Can Gilead Dominate The HIV Drug Market Again in 2014?
Motley Fool
Wednesday, March 12, 2014 - 6:58pm
tags:
HIV, Gilead Sciences, Stribild, Truvada, Atripla
Here's How Big Pfizer Is
Forbes
Wednesday, March 12, 2014 - 6:51pm
tags:
Pfizer, Celebrex
GlaxoSmithKline presents positive Phase III data for mepolizumab in severe asthma
First Word Pharma
Wednesday, March 12, 2014 - 3:22pm
tags:
GSK, mepolizumab, asthma
Pfizer says court invalidates Celebrex patent; plans to appeal
CNBC
Wednesday, March 12, 2014 - 3:08pm
tags:
Pfizer, Celebrex, patents, generics
Can Biogen Catch up to Merck in Alzheimer's Race?
Motley Fool
Wednesday, March 12, 2014 - 2:58pm
tags:
Biogen Idec, Merck, Alzheimer's disease, E2609, bapineuzumab, LY2886721, Eli Lilly, Tecfidera
German med schools perfectly OK with pharma-rep visits and gifts
Fierce Pharma Marketing
Wednesday, March 12, 2014 - 10:41am
tags:
Germany, physician access, physicians
Oxigene shares surge after positive clinical trial
Marketwatch
Wednesday, March 12, 2014 - 10:12am
tags:
Oxigene, ovarian cancer, Zybrestat
Geron Plummets as FDA Halts Development of Blood Disorder Drug
Bloomberg
Wednesday, March 12, 2014 - 10:03am
tags:
FDA, Geron, imetelstat, myelofibrosis
Company Makes Drug Available To Ailing Boy Following Public Outcry
Forbes
Wednesday, March 12, 2014 - 10:00am
tags:
Chimerix, Brincidofovir
Purdue Pill May Force Zogenix’s Rival Drug Off Market
Bloomberg
Wednesday, March 12, 2014 - 9:58am
tags:
Purdue Pharma, Zogenix, painkillers, hydrocodone, Zohydro

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.